Element Nutritional Sciences Inc. (93X.F)
- Business Wire
Element Nutritional Sciences Signs Prominent Certified Clinical Pharmacist to Represent Rejuvenate™ and Promino™ Brands
BURLINGTON, Ontario, June 02, 2022--Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the "Company" or "Element"), is pleased to announced that it has signed Dr. James LaValle to an exclusive two-year agreement to represent the Company’s patented Rejuvenate™ and Promino™ products. Dr. LaValle will appear in television and digital campaigns to highlight the company’s unique IP-driven products clinically proven to prevent muscle loss, improve tone and build muscle.
- Business Wire
Element Nutritional Sciences Reports Q1 2022 Financial Performance
BURLINGTON, Ontario, May 31, 2022--Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the "Company" or "Element"), today reports its financial results for the three months ended March 31, 2022 ("Q1 2022"). All amounts are expressed in Canadian dollars.
- Business Wire
Element Nutritional Sciences Completes Production Trials for Rejuvenate™ Muscle Activator
BURLINGTON, Ontario, May 30, 2022--Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the "Company" or "Element"), is pleased to announced that it has completed production trials for Rejuvenate™ Muscle Activator, which is expected to launch online and through the Company’s established pharmacy and grocery retail network in the United States, in the third quarter of 2022.
